期刊文献+

系统性红斑狼疮中疾病相关危险因素与早发动脉粥样硬化的关系 被引量:8

The relationship between disease-related risk factors and premature atherosclerosis in systemic lupus erythematosus
原文传递
导出
摘要 目的研究绝经期前系统性红斑狼疮(SLE)女性患者动脉粥样硬化的发病情况,探讨SLE疾病相关因素等非传统危险因素在SLE早发动脉粥样硬化中的作用。方法对111例绝经前SLE女性患者及40名健康女性进行研究。人选对象均要求无临床心血管疾病史。采用颈动脉超声检测颈部动脉粥样硬化斑块,同时测定颈动脉内膜中层厚度(1MT)。对SLE疾病相关因素与动脉粥样硬化之间的关系进行研究。采用肱动脉超声检测血管内皮功能,以此评价SLE患者与健康对照之间内皮功能的差异。采用t检验、x^2检验和Logistic回归分析等方法进行统计学分析。结果在110例绝经前SLE患者中有16例(14.4%)存在颈动脉斑块,而在40名健康对照组中无一例存在颈动脉斑块(P=0.007)。SLE患者组的平均IMT(in—IMT)(0.62mm)高于健康对照组(0.45mm)(P〈0.01),最大IMT(M—IMT)(0.7mm)高于健康对照组(0.6mm)(P〈0.01)。SLE患者中有颈动脉斑块者相对于无斑块者年龄更大,病程更长,体质量指数(BMI)更大,血压偏高,凝血酶原时问更短,C反应蛋白更高,系统性红斑狼疮损伤指数(SLICC)积分更高,累积激素剂量更大,更少使用羟基氯喹,m—IMT和M—IMT更大,血流介导的血管扩张功能(FMD)和硝酸甘油介导的血管扩张功能(NMD)减弱(P均〈0.05)。运用Logistic回归分析,在SLE患者中,年龄增大(P=0.012,OR=1.137),BMI增高(P=0.051,OR=1.205),SLICC积分增高(P=0.000,OR=2.888)是发生颈动脉斑块的独立预测指标。结论SLE患者颈动脉粥样硬化斑块的发生率明显高于健康对照。除了传统心血管疾病危险因素的影响外,SLE本身以及与疾病相关的一些因素也参与其中,对SLE早发动脉粥样硬化起重要作用。SLE患者有明显的血管内皮功能障碍,因此,内皮功能受损也可看作SLE早发动脉粥样硬化的一个表现。 Objective To evaluate the prevalence of atherosclerosis in Chinese premenopausal women with systemic lupus erythematosus (SLE) and study possible associations between non-traditional risk factors with premature atherosclerosis. Methods One hundred and eleven premeuopausal women with SLE and 40 healthy controls without clinical cardiovascular disease were evaluated. B-mode ultrasonography was used to measure carotid plaque and intima-media wall thickness(IMT). The relationship between the patients' clinical characteristics and carotid plaque was examined. At the same time, B-mode ultrasound was used to measure flow-mediated dilation (FMD) and nitroglycerin-mediated dilation (NMD) in the brachial artery. Using this method, the difference in endothelial function between SLE patients and controls was assessed. T-test, x^2 test and logistic regression were used for statistical analysis. Results Carotid plaque was more frequently observed in patients with SLE (16 of 111 patients) than in control subjects (0 of 40 subjects) (P=0.007). The mean IMT (m-IMT) (0.62 mm vs 0.45 ram, P〈0.01 ) and maximum IMT(M-IMT) (0.7 mm vs 0.6 ram, P〈0.01) was significantly higher in patients than in controls. As compared with patients without plaque, patients with plaque were significantly older, had longer disease duration, higher body mass index (BMI), higher blood pressure, shorter prothrombin time, elevated C-reactive protein level, higher SLICC score, higher cumulative prednisone dose, less hydroxychloroquine accumulated dosage, higher m-IMT and M-IMT, lower FMD and NMD. In logistic regression analysis, older age (P=0.012, OR=1.137), higher BMI (P=0.051, OR=1.205) and higher SLICC score (P=0.000, OR=2.888 ) were independently related to the presence of plaque. Conclusion SLE patients have higher prevalence of carotid atheroselerosis plaque than healthy controls and the age at onset is younger than controls. In addition to traditional risk factors for cardiovascular disease, SLE itself and disease related factors play important roles in premature atherosclerosis in SLE. SLE patients have significant endothelial dysfunction. Thus, endothelial dysfunction can be regarded as one manifestation of premature atherosclerosis in SLE.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2010年第7期468-472,共5页 Chinese Journal of Rheumatology
基金 上海市重点学科建设项目资助(T0203) 上海市级医院临床科研资源共享平台项目(SHDC12007250) 上海高校选拔培养优秀青年教师科研专项基金资助项目(jdy07036)志谢本次研究过程中得到了仁济医院风湿科顾越英教授,郭强、戴青、李挺、王晓栋、陈晓翔医师,叶萍老师的帮助,深表感谢
关键词 红斑狼疮 系统性 动脉硬化 颈动脉疾病 危险因素 内膜中层厚度 血流介导的 血管扩张功能 Lupus erythematosus, systemic Arteriosclerosis Carotid artery diseases Risk factors Intima-media wall thickness Flow-mediated dilation
  • 相关文献

参考文献15

  • 1Hahn BH.Systemic Lupus erythematosus and accelerated atherosclerosis.N Engl J Med,2003,349:2379-2380.
  • 2O'Leary DH,Polak JF,Kionmal RA,et al.Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults.Cardiovascular Health Study Collaborative Research Group.N Engl J Med,1999,340:14-22.
  • 3Anderson TJ,Uehata A,Gerhard MD,et al.Close relation of endothelial function in the human coronary and peripheral circulations.J Am Coll Cardiol,1995,26:1235-1241.
  • 4Gokce N,Keaney JF Jr,Hunter LM,et al.Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function:a prospective study.Circulation,2002,105:1567-1572.
  • 5Roman MJ,Shanker BA,Davis A,et al.Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.N Engl J Med,2003,349:2399-2406.
  • 6Jimenez S,Garcia -Criado MA,Tassies D,et al.Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.Rheumatology (Oxford),2005,44:756-761.
  • 7Selzer F,Sutton-Tyrrell K,Fitzgerald SG,et al.Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus.Arthritis Rheum,2004,50:151-159.
  • 8Svenungsson E,Jensen -Urstad K,Heimburger M,et al.Risk factors for cardiovascular disease in systemic lupus erythematosus.Circulation,2001,104:1887-1893.
  • 9Ridker PM.High-sensitivity C-reactive protein and cardiovascular risk:rationale for screening and primary prevention.Am J Cardiol,2003,92:17-22.
  • 10Hirschfield GM,Pepys MB.C-reactive protein and cardiovascular disease:new insights from an old molecule.QJM,2003,96:793-807.

同被引文献74

  • 1杜文涵,王玲,李慧,刘茵茵,申婷,胡敏.系统性红斑狼疮患者血清apo M的表达及其与疾病活动度的相关性[J].中南大学学报(医学版),2015,40(4):367-372. 被引量:12
  • 2刘敏,李彩凤,李文京.儿童1型糖尿病合并系统性红斑狼疮一例报告[J].中华糖尿病杂志(1006-6187),2005,13(3):233-233. 被引量:4
  • 3许美娟,林焕泽,刘云军,吴秀荣.65例肿瘤化疗患者使用黄芪注射液后免疫功能和预后的临床观察[J].国际医药卫生导报,2006,12(14):105-106. 被引量:4
  • 4李永法,刘玉才.黄芪注射液在肾脏疾病中的临床应用进展[J].时珍国医国药,2006,17(10):2064-2065. 被引量:19
  • 5Chung L, Krishnan E, Chakravarty EF. Hospitalizations and mor- tality in systemic sclerosis: results from the nationwide inpatient sample. Rheumatology ( oxford ), 2007,46 ( 12 ) : 1808 - 1813.
  • 6A rnett FC, Willerson JT. Connective tissue diseases and the heart.//Willerson JT, Cohn JN, Wellens HJJ, et al. Cardiovascular medicine ,3rded. London : Springer,2007:2332 - 2336.
  • 7Urowitz MB, Bookman AA, Koehler BE, et al. The bimodal mortal- ity pattern of systemic lupus erythematosus. Am J Med, 1976,60 (2) :221 -225.
  • 8Ayoub S, Hickey M J, Morand EF. Mechanisis of disease : macrophage migration inhibitory factor in SLE, RA and atherosclerosis. Nat Clin Pract Rheumatol,2008 ,d(2) :98 - 105.
  • 9Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol, 1992, 20 : 1127 - 1134.
  • 10Hahn BH, Grossman J, Chen W, et al. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases:roles of inflamma- tion and dyslipidemia. J Autoimmun,2007,28, (2) :69 -75.

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部